Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-16

Clinical Trial Update: Oral Administration of DCI to Women With PCOS [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/3 clinical trial evaluating oral D-chiro-inositol for Polycystic Ovary Syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • D-chiro-inositol (D-chiro-inositol)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Polycystic Ovary Syndrome | Phase 2, Phase 3 | Status: TERMINATED